期刊文献+

氨甲蝶呤的副作用——粘膜炎发生与修复机制的研究进展 被引量:11

下载PDF
导出
摘要 对氨甲蝶呤并发粘膜炎的发生与修复机制及与粘膜修复有关的细胞因子进行了阐述 。
出处 《中国小儿血液》 2003年第5期231-236,共6页 China Child Blood
  • 相关文献

参考文献28

  • 1叶辉.大剂量甲氨蝶呤治疗急性淋巴细胞白血病的研究进展[J].中华血液学杂志,1999,20(2):110-112. 被引量:74
  • 2童宇红,顾龙君,蔡威.儿童肿瘤的血脂和氨基酸代谢变化[J].临床儿科杂志,1998,16(5):315-317. 被引量:2
  • 3李苏,何有兼,廖海.大剂量氨甲蝶呤治疗恶性肿瘤的血药浓度监测[J].中国医院药学杂志,2001,21(4):201-203. 被引量:5
  • 4Sonis ST,Van-Vugt AG,McDonald J,et al.Mitigating effect of interleukin-11 on consecutive courses of 5-fluorouracil-induced Ulcerative mucositis in hasters.Cytokine.1997 Aug;9(8):605
  • 5Sonis ST, Muska A, O' Brien J, et al. Alteratio in tle frequincy, Severity and duration of chemotherapy-induced mucositis in hammsters by interleukin-11. Eur-J-Cancer-B-Oral-Oncol. 1995 Jul:31B(4) :261.
  • 6Herrstedt J.Prevention and managment of mucositis in patient with Cancer.Int-J-Antimicrob-Agents.2000 Oct,16(20:161
  • 7Sonis ST,Peterson RL,Edward LJ,et al.Defining mechanisms of action of interleukin-11 on the progression of radiationinduced oral mucositis in hamsters.Oral-Oncol.2000 Jul;36(4):373
  • 8Booth C and Potten CS, Effect of IL-11 on the growth of intestinal epithelial cells in vitro. Cell Prolif.1995;28,28:581.
  • 9Potten CS,Booth D,Haley JD.Pretreatment with transforming growth factor beta-3 protects small intestinal stem cell against radiation damage in vivo.British Journal of Cancer.1997,75(10):1454
  • 10Mc cormack ES,Borzillo GV,Ambrosion C,et al.Transforming Growth Factor-β3 protection of Epithelial cells from cycle-selective chemotherapy in vitro.Biochem-Pharmacol.1997 Apr 25,53(8):1149

二级参考文献14

  • 1顾龙君 应大明 等.大剂量氨甲蝶呤对急性淋巴细胞白血病庇护所治疗的探讨[J].中华血液学杂志,1986,7(5):277-286.
  • 2刘华.氨基酸和蛋白质代谢与肿瘤生长及宿主营养的关系[J].国外医学:内科学分册,1987,14:198-198.
  • 3[1]Seidenman P.Methotrexate-the relationship between dose and clinical effect[J].Br J Rheumatol,1993,32(8):751
  • 4[2]Albertioni F,Rask C,Eksborg S,et al.Evaluation of clinical assays for measuring high-dose methotrexate in plasma[J].Clinical Chemistry.1996,42(1):39
  • 5[3]Treon SP,Chabner BA.Concepts in use of high-dose methotrexate therapy[J].Clinical Chemistry,1996,42(pt2):1322-1329
  • 6[4]Grigg A.Folic Acid rescue after methotrexate[J].Bone Marrow Transplant.1993,11(3):1251
  • 7[5]Bagarry-Liegey D,Nicoara A, Daffaud F,et al.Individual dose adjustment of high-dose methotrexate in clinical practice[J]. Revue de Medicine Interne,1996,17(8):689
  • 8[6]Yacigi A,Ezzat A.Pharmacokinetic monitoring of anticancer drugs at King Faisal specialist Hospital[J].Riyadh,Saudi Arabia.Therapeutic Drug Monitoring,1997,19(4):390
  • 9顾龙君,中华血液学杂志,1986年,7卷,277页
  • 10Kern KA, Norton JA. Cancer cachexia. Parenter Enter Nutr, 1988,12:286.

共引文献77

同被引文献51

引证文献11

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部